MYCN and cholangiocarcinoma: MYCN mRNA is a direct target of miR-520c-3p in cholangiocarcinoma, and transcription factor SP1-induced lncRNA HOXD-AS1 enhances MYCN expression through competitively binding to miR-520c-3p, which associates with lymph node invasion, advanced TNM stage and poor prognosis (107).